NCT03778229 · Interventional trial
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib
Overall registry status Active not recruiting
Phase 2
Conditions Carcinoma
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory